Literature DB >> 6612331

Increased brain size and cellular content in infant rats treated with an opiate antagonist.

I S Zagon, P J McLaughlin.   

Abstract

From birth to day 21, rat offspring received daily injections of naltrexone at a dosage that blocked morphine-induced analgesia 24 hours a day. At 21 days, body, brain, and cerebellar weights of naltrexone-injected animals were 18, 11, and 5 percent greater than corresponding control weights. In addition, morphometric analysis of the cerebrum revealed a somatosensory cortex that was 18 percent thicker than that of the controls. The cerebellum of naltrexone-treated rats was 41 percent larger in total area and contained at least 70 percent more glial cells and 30 percent more granule neurons. Neurons derived prenatally were unaffected by drug treatment. These results show that naltrexone can stimulate body and brain growth in rats and suggest a role for the endorphin and opiate receptor system in development.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6612331     DOI: 10.1126/science.6612331

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  31 in total

1.  Mu-opioid agonist inhibition of kappa-opioid receptor-stimulated extracellular signal-regulated kinase phosphorylation is dynamin-dependent in C6 glioma cells.

Authors:  L M Bohn; M M Belcheva; C J Coscia
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

Review 2.  Anesthetic-related neurotoxicity and the developing brain: shall we change practice?

Authors:  Laszlo Vutskits
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

Review 3.  Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability.

Authors:  Kurt F Hauser; Valeriya K Khurdayan; Robin J Goody; Avindra Nath; Alois Saria; James R Pauly
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

4.  Internalization of the opioid growth factor, [Met5]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferation.

Authors:  Fan Cheng; Patricia J McLaughlin; William A Banks; Ian S Zagon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-30       Impact factor: 3.619

Review 5.  HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Authors:  Kurt F Hauser; Nazira El-Hage; Anne Stiene-Martin; William F Maragos; Avindra Nath; Yuri Persidsky; David J Volsky; Pamela E Knapp
Journal:  J Neurochem       Date:  2006-12-01       Impact factor: 5.372

6.  Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse.

Authors:  Y Zhu; M S Hsu; J E Pintar
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

7.  Regulation of the expression of the proenkephalin gene in cultured meningeal fibroblasts: opposite effects of alpha 1- and beta 2-adrenoceptors.

Authors:  B Hildebrand; B Wissler; C Olenik; D K Meyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

8.  Chronic treatment of newborn rats with naltrexone alters astrocyte production of nerve growth factor.

Authors:  K Mitsuo; J P Schwartz
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

9.  Glial expression of the proenkephalin gene in slice cultures of the subventricular zone.

Authors:  L Just; C Olenik; D K Meyer
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.